LEARNING FROM ERROR - WHO
Patient Safety Workshop 3 After an error that has harmed a patient has occurred, we often ask the question: how did this happen? It can be very tempting to apportion blame
Download LEARNING FROM ERROR - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
DRUG NAME: VINCRISTINE - BC Cancer
www.bccancer.bc.caVincristine DRUG NAME: VINCRISTINE SYNONYM(S)1,2: LCR; Leurocristine; VCR COMMON TRADE NAME(S)1: ONCOVIN® CLASSIFICATION: Mitotic inhibitor, cytotoxic Special pediatric considerations are noted when …
2013 Institute for Safe Medication Practices Patient ...
www.chemotherapy.vc.ons.orgUpdate during a shortage. Remember to update all information sources when the strength or dosage form of a drug is different than usual during a drug shortage.
HIGHLIGHTS OF PRESCRIBING INFORMATION The …
www.gene.comfull prescribing information warning: fatal infusion reactions, severe mucocutaneous reactions, hepatitis b virus reactivation and progressive
Get to Know an Enzyme: CYP3A4 - Hansten and Horn
www.hanstenandhorn.comDrs. Horn and Hansten are both profes-sors of pharmacy at the University of Washington School of Pharmacy. For an electronic version of this article, includ-
Nordic Protocol (Maxi-CHOP and High Dose …
www.londoncanceralliance.nhs.ukNordic Protocol (Maxi-CHOP and High Dose Cytarabine) for Mantle Cell Lymphoma (MCL) Page 1 of 3 Reason for Update: Network Protocol Development Approved by Consultant: Paul Fields
2.07 Protocol Name: CHOP & Rituximab
www.londoncanceralliance.nhs.uk2 07 R-CHOP Version 2 0 Jul08.doc Page 1 of 5 2.07 Protocol Name: CHOP & Rituximab Indication • Intermediate and high grade, B-cell non-Hodgkins
VINCRISTINE SULFATE INJECTION - Medsafe
www.medsafe.govt.nzData Sheet – New Zealand Version 5.0 3 Vincristine is a vesicant and may cause a severe local reaction on extravasation. If leakage into the
DIFFUSE LARGE B-CELL LYMPHOMA
www.who.intDIFFUSE LARGE B-CELL LYMPHOMA Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines !! ! ! 1!